Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer

References

• Wiesmueller F, Kopke J, Aust D, et al. Silenced ZNF154 is associated with longer survival in resectable pancreatic cancer. Int J Mol Sci. 2019;20(21):5437. doi:10.3390/ijms20215437
   PubMed Web of Science ®Google Scholar
• Hu Y, Qi MF, Xu QL, et al. Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling. Oncotarget. 2017;8:85749–85758. doi:10.18632/oncotarget.20479
   PubMedGoogle Scholar
• Margolin G, Petrykowska H, Jameel N, Bell D, Young A, Elnitski L. Robust detection of DNA hypermethylation of ZNF154 as a pan-cancer locus with in silico modeling for blood-based diagnostic development. J Mol Diagn. 2016;18:283–298. doi:10.1016/j.jmoldx.2015.11.004
   PubMed Web of Science ®Google Scholar
• Reinert T, Borre M, Christiansen A, Hermann G, Ørntoft T, Dyrskjøt L. Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation. PLoS One. 2012;7(10):e46297. doi:10.1371/journal.pone.0046297
   PubMed Web of Science ®Google Scholar
• González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130(4):745–753. doi:10.1002/ijc.26430
   PubMed Web of Science ®Google Scholar
• Cheung KF, Lam CN, Wu K, et al. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer. 2012;118:947–959. doi:10.1002/cncr.26189
   PubMed Web of Science ®Google Scholar
• Yu J, Cheng YY, Tao Q, et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 2009;136:640–651. doi:10.1053/j.gastro.2008.10.050
   PubMed Web of Science ®Google Scholar
• Germack R, Dickenson JM. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 2004;37:989–999. doi:10.1016/j.yjmcc.2004.08.001
   PubMedGoogle Scholar
• Sung HJ, Kim Y, Kang H, et al. Inhibitory effect of trolox on the migration and invasion of human lung and cervical cancer cells. Int J Mol Med. 2012;29:245–251. doi:10.3892/ijmm.2011.832
   PubMed Web of Science ®Google Scholar
• Zhou B, Chen H, Wei D, et al. A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2014;33(1):55. doi:10.1186/1756-9966-33-55
   PubMedGoogle Scholar
• Das B, Chowdhury C, Kumar D, et al. Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent. Bioorg Med Chem Lett. 2010;20:6947–6950. doi:10.1016/j.bmcl.2010.09.126
   PubMed Web of Science ®Google Scholar
• Smith DD, Schwarz RR, Schwartz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114–7124. doi:10.1200/JCO.2005.14.621
   PubMed Web of Science ®Google Scholar
• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. doi:10.1038/35057062
   PubMed Web of Science ®Google Scholar
• Tupler R, Perini G, Green MR. Expressing the human genome. Nature. 2001;409(6822):832–833. doi:10.1038/35057011
   PubMed Web of Science ®Google Scholar
• Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23:53. doi:10.1186/s12929-016-0269-9
   PubMed Web of Science ®Google Scholar
• Ye Q, Liu J, Xie K. Zinc finger proteins and regulation of the hallmarks of cancer. Histol Histopathol. 2019;34:1097–1109. doi:10.14670/HH-18-121
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liang P, Geng H, et al. A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas. Mol Cancer Res. 2012;10:925–936. doi:10.1158/1541-7786.MCR-11-0594
   PubMed Web of Science ®Google Scholar
• Deng J, Liang H, Ying G, et al. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer. Oncotarget. 2015;6:4482–4495. doi:10.18632/oncotarget.2916
   PubMedGoogle Scholar
• Yu J, Liang QY, Wang J, et al. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer. Oncogene. 2013;32:307–317. doi:10.1038/onc.2012.54
   PubMed Web of Science ®Google Scholar
• Vedeld HM, Andresen K, Eilertsen IA, et al. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer. 2015;136:844–853. doi:10.1002/ijc.29039
   PubMed Web of Science ®Google Scholar
• Jiang S, Linghu E, Zhan Q, Han W, Guo M. Methylation of ZNF331 promotes cell invasion and migration in human esophageal cancer. Curr Protein Pept Sci. 2015;16:322–328. doi:10.2174/138920371604150429155255
   PubMed Web of Science ®Google Scholar
• Hill VK, Ricketts C, Bieche I, et al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 2011;71:2988–2999. doi:10.1158/0008-5472.CAN-10-4026
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519–525. doi:10.1038/nature11404
   PubMed Web of Science ®Google Scholar
• Shen J, Wang S, Zhang YJ, et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology. 2012;55:1799–1808. doi:10.1002/hep.25569
   PubMed Web of Science ®Google Scholar
• Kolbe DL, DeLoia JA, Porter-Gill P, et al. Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype. PLoS One. 2012;7:e32941. doi:10.1371/journal.pone.0032941
   PubMed Web of Science ®Google Scholar
• Arai E, Chiku S, Mori T, et al. Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Carcinogenesis. 2012;33:1487–1493. doi:10.1093/carcin/bgs177
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Klee EW, Young CY, et al. Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res. 2012;18:2882–2895. doi:10.1158/1078-0432.CCR-11-2090
   PubMed Web of Science ®Google Scholar
• Sánchez-Vega F, Gotea V, Petrykowska HM, et al. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines. Epigenetics. 2013;8:1355–1372.
   PubMed Web of Science ®Google Scholar
• Carr I. Lymphatic metastasis. Cancer Metastasis Rev. 1983;2:307–317. doi:10.1007/BF00048483
   PubMed Web of Science ®Google Scholar
• Zhang X-Y, Lu W-Y. Recent advances in lymphatic targeted drug delivery system for tumor metastasis. Cancer Biol Med. 2014;11(4):247–254. doi:10.7497/j.issn.2095-3941.2014.04.003
   PubMedGoogle Scholar